---
title: "Keros Therapeutics Director Jean Jacques Bienaime buys USD 10,610 in common shares"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/293070873.md"
description: "Keros Therapeutics director Jean Jacques Bienaime purchased 1,000 common shares at a weighted-average price of $10.61, totaling $10,610. Following this transaction, his direct shareholding increased to 18,592 shares."
datetime: "2026-07-17T20:10:33.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/293070873.md)
  - [en](https://longbridge.com/en/news/293070873.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/293070873.md)
generator: "portal-rs"
---

# Keros Therapeutics Director Jean Jacques Bienaime buys USD 10,610 in common shares

-   Keros Therapeutics director Jean Jacques Bienaime bought 1,000 common shares at a weighted-average price of USD 10.61. \* His direct holding rose to 18,592 shares following the purchase. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Keros Therapeutics Inc published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001221590-26-000023), on July 17, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here

### Related Stocks

- [KROS.US](https://longbridge.com/en/quote/KROS.US.md)

## Related News & Research

- [Keros Therapeutics director Jean Jacques Bieneaime acquires USD 10,270 in common shares](https://longbridge.com/en/news/296395349.md)
- [Keros Therapeutics director Charles W. Newton sells 551 common shares worth $5,675.3](https://longbridge.com/en/news/296531453.md)
- [eDreams Odigeo buys back 60,000 shares at average price EUR 5.51 under stabilization program](https://longbridge.com/en/news/297501270.md)
- [Mercury Systems CEO William L. Ballhaus sells USD 13.89 million in common shares](https://longbridge.com/en/news/297233246.md)
- [Cellnex buys back 480,441 shares at average price EUR 26.55 under stabilization program](https://longbridge.com/en/news/297551161.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**